×

India

Covaxin Trial Results On Children Likely To Be Out By September: Randeep Guleria

New Delhi: Trials for Bharat Biotech’s Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria said. ”Vaccines for children should come out now because trials in India are already underway for vaccines which are available in India. Bharat… Continue reading Covaxin Trial Results On Children Likely To Be Out By September: Randeep Guleria

29895
A Child playing with his mask in New Delhi (PTI Photo)

New Delhi: Trials for Bharat Biotech’s Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria said.

”Vaccines for children should come out now because trials in India are already underway for vaccines which are available in India. Bharat Biotech’s trial is in the final phase and by September we will have the data,” Guleria told ANI.

ALSO READ: Batla House Encounter: Ariz Khan Moves Delhi HC Against Death Penalty

He added, “In the coming weeks or by September, vaccines should be available for children. We should then start schools in a graded manner as we have been doing for 18-45 years age and that also will give more protection to kids and more confidence to the public that children are safe.”

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

“Zydus Cadila vaccine has also included children and their data is already there. They have already applied for the emergency use authorization,” he said.

The Government of India has been holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer, for procuring their vaccine. However, there has been a delay over the same.

ALSO READ: CBI Conducts Raids in J-K Over Irregularities in Arms License Issuance

“There could be multiple reasons of delay. I think two or three things need to be kept in mind – One is collaboration and the understanding with the government on the doses. They should have enough doses to give because we must understand that these companies have pre-booked the order from many countries,” he said.

(With inputs from ANI)